All articles tagged: Coronavirus infection, unspecified (B34.2)

Higher COVID-19 vaccination rates are associated with a lower prevalence of parent-reported childhood asthma symptoms, according to a research letter published online July 3 in JAMA Network Open.Matthew M. Davis, M.D., from Nemours Children's Health in Wilmington, Delaware, and Lakshmi K. Halasyamani, M.D., from Endeavor Health in Eva

As a summer wave of COVID infections rolls across the country, U.S. health officials have recommended that all Americans over the age of 6 months get one of the updated COVID vaccines when they become available this fall.The recommendation was issued Thurs

As scorching summer temperatures drive Americans indoors and millions travel for vacations and family gatherings, COVID infections are again climbing, U.S. health officials warned Monday.In evidence that suggests a COVID summer wave is underway, case counts are most likely increasing in 39 states and aren’t declining anywhere in the c

The CDC shortens isolation for COVID-19 from 10 to 5 days for most patients. This change aims to balance public health with societal needs amid Omicron surge. However, individuals should still wear masks for 5 additional days when around others.

The risk for prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) varies across immunosuppressive conditions, according to a study published in the Jan. 24 issue of Science Translational Medicine.Yijia Li, M.D., from Harvard Medical School in Boston, and colleagues performed a detailed viro-immunologic analysis of a

Declines in cardiovascular disease (CVD) seen from 2010 to 2019 reversed in 2020 and remained high through 2022, according to a study published online Nov. 14 in the American Journal of Preventive Medicine.Rebecca C. Woodruff, Ph.D., from the U.S. Centers for Disease Control and Prevention in Chamblee, Georgia, and colleagues describe t

Many patients with mild-to-moderate COVID-19 infection at high risk for progression are not offered antiviral medication treatment, according to research published in the Jan. 25 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Paul A. Monach, M.D., Ph.D., from the VA Boston Cooperativ

Maternal COVID-19 vaccination is associated with reduced frequency of neonatal respiratory distress (RD), according to a study published online Jan. 24 in Nature Communications.Olivia M. Man, from the David Geffen School of Medicine at the University of California in Los Angeles, and colleagues examined the association between matern

The U.S. National Institutes of Health is investigating COVID-19 experiments at Boston University that have sparked a media firestorm, with some news outlets alleging that scientists created a "killer" strain of the coronavirus as part of their research.

Wastewater testing is effective in detecting infections like mpox, with a 32% likelihood of detection. It's a valuable tool for early disease detection and monitoring, including COVID-19, and will expand to track antibiotic-resistant germs and food poisoning bugs.

COVID-19 immunization completion is nearly half for people with versus without sickle cell disease (SCD), according to a research letter published online Jan. 8 in JAMA Network Open.Hannah K. Peng, from the University of Michigan in Ann Arbor, and colleagues assessed COVID-19 immunization coverage among 3,424 Michigan residents wit

During the first year of the COVID-19 pandemic, the incidence of head and neck cancer (HNC) decreased, according to a study published online Jan. 11 in JAMA Otolaryngology-Head & Neck Surgery.Jason Semprini, Ph.D., from the University of Iowa College of Public Health in Iowa City, and colleagues examined the change in localized vers

A vegetarian diet is associated with a lower incidence of COVID-19 infection, according to a study published online Jan. 9 in BMJ Nutrition, Prevention & Health.Júlio César Acosta-Navarro, M.D., Ph.D., from Universidade de Sao Paulo in Brazil, and colleagues examined whether there is an association between a plant-based or vege

The article discusses the emergence of the JN.1 variant, which has become the dominant strain in the United States, raising concerns about its potential impact on COVID-19 cases.

The World Health Organization has labeled the COVID variant JN.1 as a "variant of interest." While it's not more severe, it accounts for 21% of new cases in the U.S., mainly in the Northeast. Current tests and treatments are still effective, but caution is advised during the holiday season to prevent transmission.

The pandemic has reached a "transition point," the World Health Organization said Monday. Still, that does not mean the public health emergency of international concern (PHEIC) designation declared by the WHO in January 2020 is over yet. The organization's International Health Regulations Emergency Committee met last week to discuss COVID

Many nursing home residents and adults have not been vaccinated for influenza, COVID-19, or respiratory syncytial virus (RSV) for the 2023 to 2024 season, according to research published in the Dec. 22 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Hannah E. Reses, M.P.H., from the C

The U.S. Centers for Disease Control and Prevention is warning of a highly mutated COVID-19 variant, the prevalence of which has tripled in the past two weeks. Now, nearly one in 10 new COVID-19 cases are fueled by the BA.2.86 variant.The variant is spreading the fastest in the Northeast: Just over 13 percent of cases in the New York and New Je

Fluvoxamine does not reduce duration of COVID-19 symptoms in patients with mild or moderate COVID-19, according to a study published online Nov. 17 in the Journal of the American Medical Association. Thomas G. Stewart, Ph.D., from the University of Virginia in Charlottesville, and colleagues from the Accelerating COVID-19 The

COVID-19 vaccination before infection is associated with a reduced risk for post-COVID-19-condition (PCC), according to a study published online Nov. 22 in The BMJ.Lisa Lundberg-Morris, from the University of Gothenburg in Sweden, and colleagues conducted a population-based cohort study to examine the effectiveness of primary COVID-19 v

The prevalence of olfactory dysfunction (OD) and gustatory dysfunction (GD) declines in the three years after COVID-19 infection, according to a research letter published online Nov. 9 in JAMA Otolaryngology-Head & Neck Surgery.Paolo Boscolo-Rizzo, M.D., from the University of Trieste in Italy, and colleagues estimated the three-

For patients receiving nirmatrelvir-ritonavir (N-R) for acute COVID-19, virologic rebound (VR) occurs in about one in five, according to a study published online Nov. 14 in the Annals of Internal Medicine.Gregory E. Edelstein, from Brigham and Women's Hospital in Boston, and colleagues conducted an observational study to compare the fr

Coadministration of the BNT162b2 BA.4/5 bivalent mRNA COVID-19 vaccine (BNT162b2-biv) and seasonal influenza vaccine (SIV) generally has similar effectiveness against COVID-19- and SIV-related outcomes compared with administration of each vaccine alone, according to a study published online Nov. 8 in JAMA Network Open.Leah J. McGrath,

More women were diagnosed with interstitial cystitis/bladder pain syndrome (IC/BPS) during than before the COVID-19 pandemic, but the difference was not statistically significant, according to a study published online Sept. 12 in LUTS: Lower Urinary Tract Symptoms.Tahireh Markert, M.D., from Harvard Medical School in Boston, and colleagu

The annual meeting of the Infectious Diseases Society of America was held this year from Oct. 11 to 15 in Boston and attracted participants from around the world, including scientists, physicians, and other health care professionals. The conference featured education courses and comprehensive educational programs that focused on the latest advances in the d

Americans have been getting COVID-19 treatments such as Paxlovid for free, but that is about to end. The medications will enter the private market this week, the Associated Press reported.The price for a five-day course of Paxlovid, made by Pfizer, will be $1,390. Merck has not confirmed a price for its COVID-19 treatment, Lagevrio, but